Carlsmed (CARL) vs Tactile Systems Technology (TCMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Carlsmed (CARL) has outperformed Tactile Systems Technology (TCMD) over the past year, gaining 39.5% versus a loss of 0.4%. Tactile Systems Technology is the larger company by market cap ($573.5 million vs $477.4 million), about 1.2 times the size, while Carlsmed is growing revenue faster (+85.9% vs +12.5%). Tactile Systems Technology converts more of its revenue into profit, with a net margin of 5.8% versus -58.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CARL | TCMD |
|---|---|---|
| Share price | $17.42 | $25.60 |
| Market cap | $477.38M | $573.48M |
| 1-day change | +1.16% | -1.50% |
| YTD return | +41.05% | -11.72% |
| 1-year return | +39.47% | -0.39% |
| 5-year return | — | +23.85% |
| P/E ratio (TTM) | — | 24.85 |
| Forward P/E | — | 17.41 |
| EPS (TTM) | $-1.13 | $1.03 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $50.51M | $329.52M |
| Revenue growth (YoY) | +85.94% | +12.47% |
| Net income (latest FY) | $-29.63M | $19.09M |
| Gross margin | 75.31% | 75.91% |
| Operating margin | -60.53% | 8.89% |
| Net margin | -58.67% | 5.79% |
| 52-week high | $19.15 | $37.77 |
| 52-week low | $8.50 | $20.53 |
| Distance from 52-week high | -9.05% | -32.22% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +26.29% | +41.91% |
| Average volume | 112.80K | 248.63K |
| Shares outstanding | 27.40M | 22.40M |
| Employees | 127 | 1,086 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CARL has outperformed TCMD by 39.9 percentage points over the past year.
- Tactile Systems Technology is more profitable, keeping 5.8 cents of every revenue dollar as net income versus -58.7 cents for Carlsmed.
- Carlsmed grew revenue faster in its latest fiscal year (+85.94% vs +12.47%).
About Carlsmed
CARL stock →Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures.
Health Care · Medical/Dental Instruments · 127 employees
About Tactile Systems Technology
TCMD stock →Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds.
Health Care · Medical/Dental Instruments · 1,086 employees
CARL vs TCMD FAQ
Which is bigger, Carlsmed or Tactile Systems Technology?
Tactile Systems Technology (TCMD) is larger, with a market capitalization of $573.48M compared with $477.38M for Carlsmed (CARL).
Which stock has performed better over the past year, CARL or TCMD?
CARL returned +39.47% over the past 12 months, compared with -0.39% for TCMD (price return, excluding dividends). Past performance does not predict future results.
Are Carlsmed and Tactile Systems Technology in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.